MII IG Kerndatensatz-Modul Molekulares Tumorboard
2026.0.0 - release Unknown region code '276'

MII IG Kerndatensatz-Modul Molekulares Tumorboard, published by Medizininformatik-Initiative. This guide is not an authorized publication; it is the continuous build for version 2026.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/medizininformatik-initiative/kerndatensatzmodul-molekulares-tumorboard/ and changes regularly. See the Directory of published versions

: 20.09.2023 Z5 Mirvetuximab soravtansine 6mg/kg KG, Wdh d22 - TTL Representation

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:MedicationStatement ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "MII-EXA-MTB-Systemische-Therapie-Medication-5"] ; # 
  fhir:meta [
    ( fhir:profile [
fhir:v "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemtherapie-medication-statement"^^xsd:anyURI ;
fhir:l <https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemtherapie-medication-statement>     ] [
fhir:v "https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement|2026.0.0"^^xsd:anyURI ;
fhir:l <https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement?version=2026.0.0>     ] )
  ] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationStatement MII-EXA-MTB-Systemische-Therapie-Medication-5</b></p><a name=\"MII-EXA-MTB-Systemische-Therapie-Medication-5\"> </a><a name=\"hcMII-EXA-MTB-Systemische-Therapie-Medication-5\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profiles: <a href=\"StructureDefinition-mii-pr-mtb-systemtherapie-medication-statement.html\">MII PR MTB Systemtherapie Medication Statement</a>, <a href=\"https://simplifier.net/resolve?scope=de.basisprofil.r4@1.5.4&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement|2026.0.0\">https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-systemische-therapie-medication-statement|2026.0.0</a></p></div><p><b>basedOn</b>: <a href=\"MedicationRequest-mii-exa-mtb-medication-request-mirvetuximab.html\">MedicationRequest: extension = 1,m1A,http://doi.org#10.1200/JCO.2022.40.16_suppl.5512,http://www.ncbi.nlm.nih.gov/pubmed#38055253; status = completed; intent = proposal; medication[x] = MIRVETUXIMAB SORAVTANSINE; authoredOn = 2023-03-28</a></p><p><b>partOf</b>: <a href=\"Procedure-MII-EXA-MTB-Systemische-Therapie-1.html\">Procedure Zytostatische Chemotherapie, Immuntherapie und antiretrovirale Therapie</a></p><p><b>status</b>: Completed</p><p><b>statusReason</b>: <span title=\"Codes:\">E</span></p><p><b>medication</b>: <span title=\"Codes:{http://fdasis.nlm.nih.gov 98DE7VN88D}, {http://fhir.de/CodeSystem/bfarm/atc L01FX26}\">MIRVETUXIMAB SORAVTANSINE</span></p><p><b>subject</b>: <a href=\"Patient-PatientKimMusterperson.html\">Kim Musterperson  (no stated gender), DoB: 1956-03-14</a></p><p><b>effective</b>: 2023-09-20 --&gt; 2023-09-20</p><p><b>note</b>: </p><blockquote><div><p>20.09.2023 Z2 Mirvetuximab soravtansine 6mg/kg KG, Wdh d22</p>\n</div></blockquote><blockquote><p><b>dosage</b></p><h3>DoseAndRates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Dose[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>6 mg/kg KG<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM  codemg/kg{KG} = 'mg/kg{KG}')</span></td></tr></table></blockquote></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:basedOn ( [
fhir:l fhir:MedicationRequest/mii-exa-mtb-medication-request-mirvetuximab ;
fhir:reference [ fhir:v "MedicationRequest/mii-exa-mtb-medication-request-mirvetuximab" ]
  ] ) ; # 
  fhir:partOf ( [
fhir:l fhir:Procedure/MII-EXA-MTB-Systemische-Therapie-1 ;
fhir:reference [ fhir:v "Procedure/MII-EXA-MTB-Systemische-Therapie-1" ]
  ] ) ; # 
  fhir:status [ fhir:v "completed"] ; # 
  fhir:statusReason ( [
    ( fhir:coding [
fhir:code [ fhir:v "E" ]     ] )
  ] ) ; # 
  fhir:medication [
a fhir:CodeableConcept ;
    ( fhir:coding [
fhir:system [
fhir:v "http://fdasis.nlm.nih.gov"^^xsd:anyURI ;
fhir:l <http://fdasis.nlm.nih.gov>       ] ;
fhir:code [ fhir:v "98DE7VN88D" ] ;
fhir:display [ fhir:v "MIRVETUXIMAB SORAVTANSINE" ]     ] [
fhir:system [
fhir:v "http://fhir.de/CodeSystem/bfarm/atc"^^xsd:anyURI ;
fhir:l <http://fhir.de/CodeSystem/bfarm/atc>       ] ;
fhir:version [ fhir:v "2025" ] ;
fhir:code [ fhir:v "L01FX26" ] ;
fhir:display [ fhir:v "Mirvetuximab soravtansin" ]     ] )
  ] ; # 
  fhir:subject [
fhir:l fhir:Patient/PatientKimMusterperson ;
fhir:reference [ fhir:v "Patient/PatientKimMusterperson" ]
  ] ; # 
  fhir:effective [
a fhir:Period ;
fhir:start [ fhir:v "2023-09-20"^^xsd:date ] ;
fhir:end [ fhir:v "2023-09-20"^^xsd:date ]
  ] ; # 
  fhir:note ( [
fhir:text [ fhir:v "20.09.2023 Z2 Mirvetuximab soravtansine 6mg/kg KG, Wdh d22" ]
  ] ) ; # 
  fhir:dosage ( [
    ( fhir:doseAndRate [
fhir:dose [
a fhir:Quantity ;
fhir:value [ fhir:v "6"^^xsd:decimal ] ;
fhir:unit [ fhir:v "mg/kg KG" ] ;
fhir:system [
fhir:v "http://unitsofmeasure.org"^^xsd:anyURI ;
fhir:l <http://unitsofmeasure.org>         ] ;
fhir:code [ fhir:v "mg/kg{KG}" ]       ]     ] )
  ] ) . #